제품 세부정보
Application
- Immunization
- Cell based assay (FACS or functional assay)
- Screening (ELISA)
Synonyms
GPRC5D, G-protein coupled receptor family C group 5 member D
Source
Human GPRC5D Full Length Protein (VLP) (GPD-H52P7) is expressed from human 293 cells (HEK293). It contains AA Tyr 2 - Val 345 (Accession # Q9NZD1-1).
Predicted N-terminus: Asp
Molecular Characterization
*The isotype control of empty/mock VLP (Cat. No. VLP-N5213) is sold separately and not included in protein, you can follow the link for product information.
Structure

Virus-like particles (VLPs) are protein particles that mimic the shape of viruses but lack a viral genome, and incorporating transmembrane proteins on the external surface.
Synthesis Process
Envelope virus-like particles (eVLPs) are produced by co-expressing target membrane proteins with viral structural proteins in mammalian cells, enabling native embedding of membrane proteins into the lipid bilayer during VLP budding. This approach preserves authentic conformation, post-translational modifications, and orientation, while creating a completely detergent-free environment with repetitive multivalent display and strong immunogenicity making them ideal for immunization, binding assays in antibody discovery and screening (ELISA), and cell-based assays such as FACS, etc.
Endotoxin
Less than 1.0 EU per μg by the LAL method / rFC method.
Purity
>95% as determined by SEC-HPLC.
Formulation
The VLPs are highly immunogenic, so the immunization strategy should be optimized (antigen dose, regimen and adjuvant).
Supplied as 0.2 μm filtered solution in PBS, Arginine, pH7.4 with trehalose as protectant.
Contact us for customized product form or formulation.
Shipping
This product is supplied and shipped with dry ice, please inquire the shipping cost.
Storage
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
- The product MUST be stored at -70°C or lower upon receipt;
- -70°C for 12 months under sterile conditions.
ACRO Quality Management System
고객님도 확인한 상품
데이터 표시
SEC-HPLC

The purity of Human GPRC5D Full Length Protein (VLP) (Cat. No. GPD-H52P7) was greater than 95% as determined by SEC-HPLC.
Bioactivity-ELISA

Immobilized Human GPRC5D Full Length Protein (VLP) (Cat. No. GPD-H52P7) at 1 μg/mL (100 μL/well) can bind Anti-GPRC5D Antibody, Human IgG4 with a linear range of 0.2-1 ng/mL (QC tested).
Protocol
Bioactivity-Stability

The accelerated stability based assay shows that Human GPRC5D Full Length Protein (VLP) (Cat. No. GPD-H52P7) is stable at 37°C for 48h.

The freeze-thaw stability based assay shows that Human GPRC5D Full Length Protein (VLP) (Cat. No. GPD-H52P7) is stable after freeze-thaw 3 times.
Identity-DLS

The mean peak Radius of VLP is 55-75 nm with more than 95% intensity as determined by dynamic light scattering (DLS).
사용자 리뷰 댓글 남기기

배경 소개
프론티어 진행
- 영어 이름:
G-protein coupled receptor family C group 5member D
- 카테고리:
- 상장 의약품 수:
1 상세
- 임상 의약품 수:
38 상세
- 최고 개발 단계:
Approved
전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521



















